Factorial Inc. ("Factorial"), the U.S. solid-state battery developer redefining what's possible in advanced energy systems, and Cartesian Growth Corporation III ("Cartesian III") today announced that ...

Festo has introduced GripperAI, a universal AI-based software that enables fulfillment-center robots to pick a range of items ...

Integrated motion control allows all kinds of robots to tackle a range of tasks with precision, in contrast with conventional machinery.

The CAR T-cell therapy market is ripe for growth with over 250 companies and 500 drugs in development globally. Key opportunities lie in targeting hematologic malignancies and overcoming challenges in ...

As of Wednesday, February 18, Cartesian Therapeutics, Inc.’s RNAC share price has dipped by 8.15%, which has investors questioning if this is right time to buy.

According to MarketsandMarketstm, the CAR T-Cell Therapy Market is estimated to reach USD 13.78 billion by 2031 from USD 7.24 billion in 2026, at a CAGR of 13.7%. Browse 300 market data Tables and 30 ...

According to MarketsandMarkets, the CAR T-Cell Therapy Market is estimated to reach USD 13.78 billion by 2031 from USD 7.24 billion in 2026 ...

Factorial Energy and Stellantis have validated a full-size solid-state battery cell that they describe as a potential ...

"We've proven our ... platform delivers what customers want." Battery company announces 'game-changer' milestone that could make EV range anxiety a thing of the past: 'Marks a pivotal inflection point ...